Wealth Enhancement Advisory Services
GSK icon

Wealth Enhancement Advisory Services’s GSK GSK Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.06M Buy
114,888
+12,789
+13% +$676K 0.01% 897
2026
Q1 		$5.56M Sell
102,099
-26,418
-21% -$1.43M 0.01% 853
2025
Q4 		$6.51M Sell
128,517
-24,912
-16% -$1.16M 0.01% 890
2025
Q3 		$6.67M Sell
153,429
-16,240
-10% -$634K 0.01% 822
2025
Q2 		$6.48M Sell
169,669
-8,841
-5% -$338K 0.01% 793
2025
Q1 		$6.92M Buy
178,510
+3,822
+2% +$140K 0.01% 717
2024
Q4 		$5.91M Buy
174,688
+13,039
+8% +$469K 0.01% 741
2024
Q3 		$6.61M Sell
161,649
-4,606
-3% -$188K 0.01% 642
2024
Q2 		$6.4M Buy
166,255
+8,989
+6% +$378K 0.02% 621
2024
Q1 		$6.74M Buy
157,266
+4,082
+3% +$168K 0.02% 592
2023
Q4 		$5.68M Buy
153,184
+78,527
+105% +$2.82M 0.02% 577
2023
Q3 		$2.71M Buy
+74,657
New +$2.65M 0.01% 757

Other funds holding GSK

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
FVWA
Foster Victor Wealth Advisors Greenville, South Carolina $1.9B AUM 24.46% 1-Year Est. Return
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return
KFP
Keystone Financial Planning Cleveland, Ohio $388M AUM 16.66% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
TH
Transmarket Holdings Chicago, Illinois $136M AUM
GC
Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return

Wealth Enhancement Advisory Services's GSK Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its GSK (GSK) stake by 13% in Q2 2026, buying an estimated $676K and bringing the position to 114,888 shares worth $6.06M. The position accounts for 0.01% of the portfolio, ranked #897.

Wealth Enhancement Advisory Services first reported a position in GSK in Q3 2023 and has held it in 12 quarters since. The position peaked at $6.92M in Q1 2025. 267 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Wealth Enhancement Advisory Services held 114,888 shares of GSK worth $6.06M as of Q2 2026.
  • Wealth Enhancement Advisory Services bought 12,789 GSK shares in Q2 2026, an estimated $676K.
  • GSK made up 0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #897 holding.
  • Wealth Enhancement Advisory Services first reported a position in GSK in Q3 2023 and has held it in 12 quarters since.
  • Wealth Enhancement Advisory Services's GSK position peaked at $6.92M in Q1 2025.
  • 267 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.